In vitro antifungal activities of isavuconazole and comparators against rare yeast pathogens

Antimicrob Agents Chemother. 2010 Sep;54(9):4012-5. doi: 10.1128/AAC.00685-10. Epub 2010 Jun 21.

Abstract

We compared the in vitro activities of isavuconazole, posaconazole, voriconazole, and fluconazole against Dipodascus capitatus (n = 21), Saccharomyces cerevisiae (n = 20), Rhodotorula mucilaginosa (n = 18), and Trichosporon spp. (n = 15). The MIC(50)s, MIC(90)s, and MIC ranges (in microg/ml) obtained using the CLSI M27-A3 procedure were as follows: isavuconazole, 0.125, 0.5, and < or = 0.015 to 2; posaconazole, 0.5, 2, and < or = 0.015 to > 16; voriconazole, 0.125, 2, and < or = 0.015 to 8; and fluconazole, 4, > 128, and < or = 0.125 to > 128. Isavuconazole showed potent activity against the isolates studied.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / pharmacology*
  • Dipodascus / drug effects
  • Fluconazole / pharmacology
  • Microbial Sensitivity Tests
  • Nitriles / pharmacology*
  • Pyridines / pharmacology*
  • Pyrimidines / pharmacology
  • Rhodotorula / drug effects
  • Saccharomyces cerevisiae / drug effects
  • Triazoles / pharmacology*
  • Trichosporon / drug effects
  • Voriconazole

Substances

  • Antifungal Agents
  • Nitriles
  • Pyridines
  • Pyrimidines
  • Triazoles
  • isavuconazole
  • posaconazole
  • Fluconazole
  • Voriconazole